| Title |
Opportunity Number |
Funding Agency |
Deadline |
|
The Armed Forces Institute for Regenerative Medicine (AFIRM)
|
MTEC-23-04-AFIRM |
MTEC |
Full proposal due 3/16/2023 |
|
MTEC Navy Multi-Topic
|
MTEC-23-05 |
MTEC |
Enhanced white paper due 2/20/2023 |
|
Peer Reviewed Alzheimer's Research Program (PRARP)
|
CDMRP Pre-Announcement |
DOD-AMRAA |
Forecasted |
|
Lung Cancer Research Program (LCRP)
|
CDMRP Pre-Announcement |
DOD-AMRAA |
Forecasted |
|
MTEC Performance
|
MTEC-23-03-Performance |
MTEC |
Enhanced White paper due 2/10/2023 |
|
Ovarian Cancer Research Program (OCRP)
|
CDMRP Pre-Announcement |
DOD-AMRAA |
Forecasted |
|
Solutions to Accelerate Return-to-Readiness following Musculoskeletal Injuries
|
MTEC-23-02 MSKI |
MTEC |
Enhanced white paper due 2/28/2023 |
|
Tuberous Sclerosis Complex Research Program (TSCRP)
|
CDMRP Pre-Announcement |
DOD-AMRAA |
Forecasted |
|
Breast Cancer Research Program (BCRP)
|
CDMRP Pre-Announcement |
DOD-AMRAA |
Forecasted |
|
Amyotrophic Lateral Sclerosis Research Program (ALSRP)
|
CDMRP Pre-Announcement |
DOD-AMRAA |
Forecasted |
|
DOD Reconstructive Transplant Clinical Network Award
|
HT9425-23-RTRP-CNA |
DOD-AMRAA |
2/1/2023 (LOI due 01/18/2023) |
|
AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research
|
NOT-HS-23-003 |
AHRQ |
See Notice |
|
Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs)
|
NOT-AI-23-013 |
NIH |
Expires January 08, 2026 |
|
Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
|
PA-21-265 |
NIH |
expires May 27, 2025 |
|
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
|
PA-22-047 |
NIH |
expires October 31, 2026 |
|
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)
|
PA-22-048 |
NIH |
expires October 31, 2026 |
|
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
|
PA-21-164 |
NIH |
expires July 18, 2024 |
|
Notice of Special Interest (NOSI): Complement in Fundamental Immunology
|
NOT-AI-23-012 |
NIH |
expires January 08, 2026 |
|
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
|
PAR-22-243 |
NIH |
expires September 08, 2025 |
|
HEAL Initiative Integrated Basic and Clinical Team-based Research in Pain (RM1 Clinical Trial Optional)
|
RFA-NS-22-069 |
NIH |
expires March 12, 2024 |
|
Epilepsy Research Program (ERP)
|
CDMRP Pre-Announcement |
DOD-AMRAA |
Forecasted |
|
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
|
PAR-23-047 |
NIH |
1/8/2026 |
|
Notice of Special Interest (NOSI): Halting Tuberculosis (TB) Transmission
|
NOT-AI-22-064 |
NIH |
1/8/2026 |
|
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
|
PAR-22-242 |
NIH |
9/8/2025 |
|
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
|
PAR-22-243 |
NIH |
9/8/2025 |
|
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
|
PAR-23-027 |
NINDS, NIAID |
10/18/2023 |
|
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early Stage Development (UG3/UH3 Clinical Trial Not Allowed)
|
PAR-22-209 |
NIH (NINDS, NEI, NIDA, NIEHS) |
10/18/2024 |
|
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
|
PAR-20-253 |
NIH (NINDS, NEI, NIDA, NIEHS, NIAID) |
5/31/2023 |
|
DoD USAMRDC FY23-FY27 Broad Agency Announcement for Extramural Medical Research
|
HT9425-23-S-BAA1 |
DOD-AMRAA |
9/30/2027 |
|
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development
|
NOT-EB-22-007 |
NIH |
Forecasted |
|
Broad Agency Announcement Research and Development In Support of The Joint Program Executive Office For Chemical, Biological, Radiological And Nuclear Defense (JPEO-CBRND), JPM MEDICAL AND JPL EB
|
W911SR-22-R-CBRN |
DOD |
6/26/2027 |
|
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
|
PAR-22-209 |
NIH |
10/18/2024 |
|
Biological Technologies - DARPA BTO Broad Agency Announcement
|
HR001122S0034 |
DOD-DARPA BTO |
4/20/2023 |
|
Airman Readiness Medical Research (ARMR) Hybrid BAA
|
FA8650-20-S-6008 |
DoD-AFRL |
5/1/2025 |
|
US Special Operations Command - Broad Agency Announcement for Extramural Biomedical Research and Development
|
W81XWH-18-S-SOC1 |
DOD-AMRAA |
7/31/2023 |
|
Research Interests of the Air Force Office of Scientific Research
|
FA9550-21-S-0001 |
DOD-AFOSR |
|
|
US Army Combat Capabilities Development Command Broad Agency Announcement
|
W911QY-20-R-0022 |
DOD-AMC-ACCAPGN |
2/28/2025 |
|
Army Applications Lab Broad Agency Announcement for Disruptive Applications
|
W911NF-19-S-0004 |
DOD-AMC |
5/1/2024 |
|
BARDA DRIVe EZ-BAA
|
BAA-20-100-SOL-0002 |
HHS - BARDA |
7/6/2024 |
|
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine
|
NOT-AI-22-013 |
NIH (NIAID) |
1/8/2025 |
|
Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery
|
NOT-AI-22-014 |
NIH (NIAID) |
1/8/2025 |
|
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
|
PAR-22-127 |
NIH (NIGMS, NIA, NCI) |
5/8/2025 |
|
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
|
PAR-22-126 |
NIH (NIGMS, NIA, NCI) |
5/8/2025 |
|
Research Program Award (R35 Clinical Trial Optional)
|
RFA-NS-22-038 |
NIH (NINDS) |
7/16/2024 |
|
Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)
|
PAR-22-076 |
NIH (NINDS) |
5/8/2025 |
|
Notice of Special Interest (NOSI): CCRP Administrative Supplement for Collaborative Science to Synergize Chemical Medical Countermeasures Discovery and Early Development
|
NOT-AI-22-029 |
NIH (NIAID, NEI, NIAMS, NIDA, NIEHS, NINDS) |
3/2/2024 |
|
Notice of Special Interest (NOSI): NIAID Administrative Supplement to Promote Discovery of Medical Countermeasures Against Chemical Threats
|
NOT-AI-22-030 |
NIH (NIAID) |
3/2/2024 |
|
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
|
NOT-HL-20-814 |
NIH (NHLBI) |
12/21/2024 |
|
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
|
RFA-HL-23-010 |
NIH (NHLBI) |
12/21/2024 |
|
Catalyze: Product Definition – Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
|
RFA-HL-23-013 |
NIH (NHLBI) |
12/21/2024 |
|
Catalyze: Product Definition – Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
|
RFA-HL-23-014 |
NIH (NHLBI) |
12/22/2024 |
|
Parkinson's Research Program (PRP)
|
W81XWH-22-PRP |
DOD-AMRAA |
09/01/22 (Pre-proposal due 8/16/22) |
|
Lupus Research Program (LRP)
|
W81XWH-22-LRP |
DOD-AMRAA |
9/1/2022 (preproposal due 8/16/2022) |
|
Tick-Borne Disease Research Program (TBDRP)
|
W81XWH-22-TBDRP |
DOD-AMRAA |
8/25/2022 (PreProposal due 5/26/2022) |
|
Spinal Cord Injury Research Program (SCIRP)
|
W81XWH-22-SCIRP |
DOD-AMRAA |
9/2/2022 (Pre-application 5/23/2022) |
|
Autism Research Program (ARP)
|
W81XWH-22-ARP |
DOD-AMRAA |
8/18/2022 (Pre-application 5/23/2022) |
|
Combat Readiness-Medical Research Program (CRRP)
|
W81XWH-22-CRRP |
DOD-AMRAA |
9/14/2022 (Pre-proposal due 6/23/2022) |
|
Peer Reviewed Orthopaedic Research Program (PRORP)
|
W81XWH-22-PRORP |
DOD-AMRAA |
9/13/2022 (PreProposal due 6/16/2022) |
|
DHA Military Health System Research (MHSR)
|
23-DHA-MHSR |
DOD-DHA |
Updated deadline: 2022-09-01 (LOI due 2022-05-03) |
|
Research Infrastructure for Trauma with Medical Observations (RITMO)
|
HR001122S0043 |
DOD-DARPA BTO |
9/1/2022 (Abstract due 7/20/2022) |
|
Society of Military Orthopaedic Surgeons Military Orthopaedic Medicine and Readiness Optimization Research Grant
|
SOMOS Research Grant |
SOMOS |
9/30/2022 (LOI 08/05/2022) |
|
Algorithm Development for Early Warning and Predication of Chemical and Biological Threat Exposure Leveraging Artificial Intelligence and Machine Learning (AI/ML) Approaches
|
MTEC-22-10 ChemBio |
MTEC |
10/17/2022 |
|
DoD USAMRDC FY18-FY22 Broad Agency Announcement for Extramural Medical Research (addendum)
|
W81XWH-18-S-BAA1 |
DOD-AMRAA |
9/30/2022 |
|
National Disaster Medical System (NDMS) - Pilot Site Projects
|
MTEC-23-01-NDMS-PSP |
MTEC |
11/16/2022 |
|
Defense Medical Research and Development Program - Battlefield Wound Management and Infection Research (DMRDP BWMIR) Award
|
W81XWH-22-S-DMRDP-BWMIR |
DOD-AMRAA |
11/16/2022 (LOI due 10/20/2022) |
|
Duchenne Muscular Dystrophy Research Program (DMDRP)
|
W81XWH-22-DMDRP |
DOD-AMRAA |
11/15/22 (Pre-proposal due 8/03/22) |
|
Vision Research Program (VRP)
|
W81XWH-22-VRP |
DOD-AMRAA |
11/9/22 (Pre-proposal due 7/15/22) |
|
Army Research Laboratory Broad Agency Announcement for Basic and Applied Scientific Research
|
W911NF-17-S-003 |
DOD-AMC |
10/31/2022 |
|
Toxic Exposures Research Program
|
W81XWH-22-TERP |
DOD-AMRAA |
12/01/2022 (LOI due 11/03/2022) |
|
Hearing Restoration Research Program (HRRP)
|
W81XWH-22-HRRP |
DOD-AMRAA |
11/30/ 2022 (Pre-proposal Due 07/22/2022) |
|
Military Medical Photonics Program
|
FOA-AFRL-AFOSR-2022-0008 |
DOD-AFOSR |
12/9/2022 (pre-proposal inquiries by 11/15/2022) |
|
FY23 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
|
FDABAA-23-00123 |
FDA |
white paper due January 23, 2023 |
|
Breast Cancer Research Program (BCRP) Clinical Research Extension Award
|
W81XWH-22-BCRP |
DOD-AMRAA |
12/13/2022 (LOI due 11/29/2022) |
|
Technology Integration to Optimize Military Health and Performance
|
MTEC-23-03-Performance Pre-Ann |
MTEC |
PreAnnouncement |
